中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
20期
170-171
,共2页
缩宫素%米索前列醇%产后出血
縮宮素%米索前列醇%產後齣血
축궁소%미색전렬순%산후출혈
Oxytocin%Misoprostol%Postpartum hemorrhage
目的:探讨针对医院产妇,观察选择缩宫素+米索前列醇在预防产后出血方面获得的效果。方法选取我院2012年2月~2015年2月产妇60例。平均分成两组,C1组(观察组30例):临床选择缩宫素+米索前列醇预防产后出血;C2组(对照组30例):临床选择缩宫素预防产后出血。对比两组产妇在产后2h出血量、产后出血率、第三产程时间以及产后24 h出血量几方面表现的差异。结果两组产妇分别完成临床治疗后,在产后出血量、第三产程时间、产后2 h出血量以及产后24 h出血量几方面,C1组优于C2组产妇(P<0.05);在不良反应发生率方面,C1组与C2组产妇未表现出显著差异(P>0.05)。结论针对产妇,临床选择米索前列醇+缩宫素进行治疗,针对产后出血能够发挥预防效果,将产妇产后出血量有效降低,将出现不良反应的概率有效降低,凸显两种药物预防产后出血的临床价值。
目的:探討針對醫院產婦,觀察選擇縮宮素+米索前列醇在預防產後齣血方麵穫得的效果。方法選取我院2012年2月~2015年2月產婦60例。平均分成兩組,C1組(觀察組30例):臨床選擇縮宮素+米索前列醇預防產後齣血;C2組(對照組30例):臨床選擇縮宮素預防產後齣血。對比兩組產婦在產後2h齣血量、產後齣血率、第三產程時間以及產後24 h齣血量幾方麵錶現的差異。結果兩組產婦分彆完成臨床治療後,在產後齣血量、第三產程時間、產後2 h齣血量以及產後24 h齣血量幾方麵,C1組優于C2組產婦(P<0.05);在不良反應髮生率方麵,C1組與C2組產婦未錶現齣顯著差異(P>0.05)。結論針對產婦,臨床選擇米索前列醇+縮宮素進行治療,針對產後齣血能夠髮揮預防效果,將產婦產後齣血量有效降低,將齣現不良反應的概率有效降低,凸顯兩種藥物預防產後齣血的臨床價值。
목적:탐토침대의원산부,관찰선택축궁소+미색전렬순재예방산후출혈방면획득적효과。방법선취아원2012년2월~2015년2월산부60례。평균분성량조,C1조(관찰조30례):림상선택축궁소+미색전렬순예방산후출혈;C2조(대조조30례):림상선택축궁소예방산후출혈。대비량조산부재산후2h출혈량、산후출혈솔、제삼산정시간이급산후24 h출혈량궤방면표현적차이。결과량조산부분별완성림상치료후,재산후출혈량、제삼산정시간、산후2 h출혈량이급산후24 h출혈량궤방면,C1조우우C2조산부(P<0.05);재불량반응발생솔방면,C1조여C2조산부미표현출현저차이(P>0.05)。결론침대산부,림상선택미색전렬순+축궁소진행치료,침대산후출혈능구발휘예방효과,장산부산후출혈량유효강저,장출현불량반응적개솔유효강저,철현량충약물예방산후출혈적림상개치。
Objective To investigate the maternity hospital for observation selection effect of oxytocin and misoprostol in preventing postpartum hemorrhage obtained. Methods 60 cases were chosen in our hospital in February 2012 ~ February 2015. Were divided into two groups, C1 group (observation group, 30 cases): clinical selection of oxytocin and misoprostol. C2 group (30 patients): clinical selection of oxytocin to prevent postpartum hemorrhage. Compared two groups of women at 2 h post-partum bleeding, postpartum hemorrhage, and the third stage of labor and postpartum hemorrhage 24 h several aspects of performance differences. Results The two groups of mothers were completed clinical treatment, postpartum hemorrhage, and the third stage of labor, postpartum hemorrhage 2 h and 24 h post-partum hemorrhage aspects, C1 C2 group was superior to women (P<0.05), the adverse reactions incidence, C1 and C2 groups were group showed no signiifcant difference (P>0.05). Conclusion For women, clinical choose misoprostol and oxytocin treatment for postpartum hemorrhage can play a preventive effect, will reduce the amount of postpartum hemorrhage, the probability of adverse effects will occur effectively reduce the highlights of the two drugs to prevent postpartum hemorrhage.